Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ QT Imaging Holdings, Inc. (QTI) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Devices
$4.04
+0.05 (1.25%)Did QTI Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if QT Imaging is one of their latest high-conviction picks.
Wall Street analysts covering QTI have a bullish consensus with a median price target of $11.60 (ranging from $10.00 to $13.20). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $4.04, the median forecast implies a 187.1% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for QTI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to QT Imaging based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
QT Imaging Holdings, Inc. has a market capitalization of $53.50M with a P/E ratio of -2.0x. The company generates $22.66M in trailing twelve-month revenue with a -58.9% profit margin.
Revenue growth is +133.4% quarter-over-quarter, while maintaining an operating margin of -36.0% and return on equity of -327.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops body imaging systems using sound waves.
The company generates revenue by researching, developing, and commercializing innovative imaging technologies, particularly its QT Breast Scanner, which aids in the detection and diagnosis of diseases. It targets medical professionals, radiologists, and patients, leveraging collaborations and partnerships to enhance its product offerings.
Founded in 2012 and based in Novato, California, QT Imaging Holdings has established strategic partnerships with companies like Olea Medical S.A.S and Intelerad Medical Systems to expand its capabilities and reach in the medical imaging market.
Healthcare
Medical Devices
31
Dr. Raluca Dinu Ph.D.
United States
2021
QT Imaging Holdings, Inc. has received clearance from Saudi Arabia's SFDA for its Breast Acoustic CTโข scanner, enabling its use as a medical device in the country.
QT Imaging's Breast Acoustic CTโข clearance in Saudi Arabia opens a new market, potentially boosting revenue and enhancing growth prospects, which can positively impact stock performance.
QT Imaging Holdings, Inc. (Nasdaq: QTI) is set to be added to the Russell Microcapยฎ Index following the 2026 reconstitution, enhancing its visibility among investors.
QT Imaging's inclusion in the Russell Microcap Index may enhance its visibility and attract institutional investment, potentially boosting its stock price and liquidity.
QT Imaging Holdings, Inc. (Nasdaq: QTI) closed a public offering of 2 million shares, raising about $10 million. The company focuses on radiation-free breast health imaging technology.
QT Imaging's $10 million stock offering boosts capital for growth and innovation in breast health, signaling potential for future developments and impacting investor sentiment around the company.
QT Imaging Holdings, Inc. announced a public offering of 2,000,000 shares of common stock, aiming to raise $10 million, with Ladenburg Thalmann & Co. as the sole book-running manager.
QT Imaging's public offering raises $10 million, indicating confidence in growth and innovation. This can impact stock valuation and investor sentiment in the medical device sector.
QT Imaging Holdings, Inc. reported Q1 2026 financial results, highlighting progress in commercialization, regulatory efforts, and clinical validation of its radiation-free breast health imaging technology.
QT Imaging's progress in commercialization and regulatory execution signals potential growth and profitability, which could positively impact its stock performance and attract investor interest.
QT Imaging Holdings, Inc. announced Dr. Barry Roseman as Senior Medical Advisor to aid in the clinical implementation of its radiation-free breast imaging technology.
Dr. Roseman's role enhances QT Imaging's credibility and may drive adoption of its technology, potentially boosting future revenue and investor confidence in the company's growth prospects.
Based on our analysis of 0 Wall Street analysts, QT Imaging Holdings, Inc. (QTI) has a median price target of $11.60. The highest price target is $13.20 and the lowest is $10.00.
According to current analyst ratings, QTI has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.04. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict QTI stock could reach $11.60 in the next 12 months. This represents a 187.1% increase from the current price of $4.04. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by researching, developing, and commercializing innovative imaging technologies, particularly its QT Breast Scanner, which aids in the detection and diagnosis of diseases. It targets medical professionals, radiologists, and patients, leveraging collaborations and partnerships to enhance its product offerings.
The highest price target for QTI is $13.20 from at , which represents a 226.7% increase from the current price of $4.04.
The lowest price target for QTI is $10.00 from at , which represents a 147.5% increase from the current price of $4.04.
The overall analyst consensus for QTI is bullish. Out of 0 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $11.60.
Stock price projections, including those for QT Imaging Holdings, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.